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injection with recombinant plasmid solution. In comparison
with the rats pretreated with Ringer’s solution or vector
plasmid, those pretreated with recombinant plasmid had a
lower mortality and lower serum transaminase levels. The
injection with recombinant plasmid signiﬁcantly reduced
hemorrhage necrosis and inﬂammatory inﬁltration in the
liver. Liver apoptotic index (AI) was dramatically lower
in rats pretreated with recombinant vectors compared
to the rats pretreated with Ringer’s solution or vector
plasmids. [(10.2±6.9)% vs. (83.1±12.6)% and (79.9±13.4)%
respectively, P < 0.01]. In addition, the expression of
exogenous Pim-3 gene remarkable inhibited the expression
and secretion of TNF-a and IL-1b (P < 0.01).
Conclusions: Pim-3 gene can protect rats from LPS/D-GalN-
induced fulminant hepatic failure possibly by inhibiting
expression and secretion of inﬂammatory cytokines, such
as TNF-a and IL-1b, in liver tissues.
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Background: Kupffer cells are one of the most important
mesenchymal cells in liver, which play a crucial role in liver
homeostasis. We report in detail a reliable and reproducible
methodology for the isolation of KC, which gives highly
puriﬁed and functionally intact cell cultures.
Methods: Firstly, a 20G catheter was inserted into rat’s
portal vein and secured with silk stitch, and then the
liver was perfused and digested with DHANKS and HANKS
containing 0.05% collagenase IV respectively; secondly, the
Kupffer cells isolated by percoll gradient; and last step,
isolated Kupffer cells were puriﬁed by selective adherence
after 2 hours of cultivation. The kupffer cell identiﬁed by
monoclonal antibody ED-2 and ED1. At same time, GFAP as
a control antibody for telling apart HSC (T6 cell line) and
Kupffer cells.
Results: This method resulted in a satisfactorily high yield
of 6 18×106 KCs per liver, over 95% positive for ED-2 and
ED1, negative for GFAP (Figures 1 3).
Conclusion: The method for isolating and culturing kupffer
cells in this study is effective and stable, and the biological
characters are preserved for further research.
Figure 1. Kuppfer cells were cultured with density of
1×106/mL/well, 20% DMEM (high glucose), 10×.
Figure 2. Immunoﬂuorescence picture of Kuppfer cells and
HSC cells.
Figure 3. India ink staining of Kuppfer cells 10×.
PP-048 Mechanism of curcumine on the suppression of
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Objective: Liver ﬁbrosis is the common pathological
basis for diverse liver injuries. Suppression of HSC
activation and prevention of hepatic ﬁbrogenesis attract
many researchers’ attention. Curcumin is used for anti-
oxidant, anti-tumor, anti-inﬂammatory effects. However, its
protective mechanism on hepatic ﬁbrosis is not clear. The
aim of the present study was to determine the mechanism of
curcumine on the transforming growth factor beta1 (TGF-b1)
and connective tissue growth factor (CTGF) pathway of
hepatic ﬁbrosis mice.
Methods: C57BL6/J mice were injected with CCL4 for 8
weeks to induce hepatic ﬁbrosis, and curcumine was given
in the treated group. The effect of curcumine was assessed
by comparing the severity of hepatic ﬁbrosis in liver sections
and the expression of TGF-b1, CTGF and smads.
Results: CCL4 induced hepatic ﬁbrosis models showed
increased serum ALT and HA levels, inﬁltration of
inﬂammation cells and ﬁbrosis, which associated with
enhanced a-SMA, TGFb1, CTGF, TGFbRII and Smad3 protein
expression and up-regulated TGFb1, CTGF and Smad3
mRNA expression. The Smad7 mRNA and protein expression
was down-regulated. Curcumine treatment signiﬁcantly
decrease serum ALT and HA levels and reduce hepatic
ﬁbrosis by repressing TGFb1, TGFbRII, CTGF, Smad3 protein
expression. It also repressing TGFb1, CTGF, Smad3 mRNA
expression. In addition, curcumine also increase smad7
mRNA and protein expression.
Conclusions: Curcumine may ameliorate hepatic ﬁbrosis
by inhibitinga-SMA activation and inhibiting TGFb1 and
CTGF signaling pathway. It shoud be a useful medicine
for improving hepatic ﬁbrosis.
